In the dynamic landscape of therapeutic development, antibody-drug conjugates (ADCs) have emerged as a ground-breaking class of...
Antibody-Drug Conjugates (ADC) and their potential therapeutic applications
read more
In the dynamic landscape of therapeutic development, antibody-drug conjugates (ADCs) have emerged as a ground-breaking class of...
Therapeutic monoclonal antibodies (mAbs) have become a dominant product class within the biopharmaceutical market. To date, therapeutic...